CRBP
Corbus Pharmaceuticals Holding
5.90$
-4.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 0.00 | 0.62 | 1.39 | 1.46 | 2.54 | 16.97 | 1.51 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | 1.87 | 5.64 | 11.26 | 15.57 | 25.59 | 42.07 | 0.04 | 0.40 | 0.36 | 7.20 | 0.05 | 0.02 | |
| – | – | -1.87 | -5.01 | -9.86 | -14.11 | -23.05 | -25.10 | 1.51 | -0.18 | -0.36 | -7.20 | -0.05 | -0.02 | |
| 2.48 | 0.24 | 1.87 | 5.64 | 11.26 | 15.57 | 25.59 | 42.07 | 37.73 | 8.89 | 3.87 | 7.20 | 2.95 | 5.26 | |
| 1.25 | 0.40 | 2.07 | 3.46 | 4.71 | 5.36 | 6.82 | 11.10 | 10.94 | 4.98 | 4.48 | 3.21 | 1.51 | 1.14 | |
| 3.56 | 0.65 | 3.94 | 9.09 | 15.97 | 20.93 | 32.41 | 11.10 | 48.67 | 13.47 | 8.00 | 10.42 | 4.41 | 6.41 | |
| -3.55 | -0.65 | -3.94 | -8.47 | -14.57 | -19.47 | -29.87 | -36.20 | -47.15 | -13.66 | -8.35 | -10.42 | -4.46 | -6.41 | |
| – | 0.05 | 0.04 | 0.00 | 0.00 | 0.11 | 0.00 | 0.01 | 0.39 | 0.45 | 0.51 | 0.68 | 0.17 | 0.00 | |
| -3.82 | -0.70 | -3.78 | -8.47 | -14.58 | -19.38 | -29.30 | -33.55 | -42.72 | -11.13 | -10.15 | -10.31 | -3.68 | -5.90 | |
| -0.27 | 0.05 | 0.04 | 0.00 | 0.01 | -0.24 | 0.57 | -1.08 | 0.01 | -0.02 | 3.23 | – | – | – | |
| -3.82 | -0.70 | -3.78 | -8.47 | -14.58 | -19.38 | -29.30 | -33.55 | -42.72 | -11.11 | -13.39 | -10.31 | -3.68 | -5.90 | |
| -0.27 | -0.65 | -3.92 | -8.43 | -14.51 | -19.32 | -29.61 | -35.85 | -46.50 | -10.29 | -9.29 | -9.27 | -3.46 | -5.88 |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.